Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
Native American tribal organizations (other)Nonprofits having 501(c)(3) statusNonprofits without 501(c)(3) statusPrivate institutions of higher educationIndividualsFor-profit organizationsSmall businessesOthersUnrestrictedState governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic/State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities
484 grants for Special district governments
Sorted by deadline (soonest first)
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
HHS-NIH11 · RFA-HG-27-012
Closes Oct 30, 2026
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
HHS-NIH11 · RFA-HG-27-013
Closes Oct 30, 2026
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
HHS-NIH11 · RFA-HG-27-011
Closes Oct 30, 2026
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-24-280
Closes Nov 2, 2026
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
HHS-NIH11 · PAR-24-279
Closes Nov 2, 2026
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-255
Closes Nov 5, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-095
Closes Nov 6, 2026
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
HHS-NIH11 · RFA-NS-26-001
Closes Nov 10, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-27-002
Closes Nov 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-27-001
Closes Nov 10, 2026
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-271
Closes Nov 13, 2026
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-269
Closes Nov 13, 2026
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
HHS-NIH11 · PAR-24-089
Closes Nov 13, 2026
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-270
Closes Nov 13, 2026
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
HHS-NIH11 · PAR-25-370
Closes Nov 16, 2026
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
HHS-NIH11 · PAR-25-274
Closes Nov 17, 2026
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-268
Closes Nov 17, 2026
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-267
Closes Nov 17, 2026
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
HHS-NIH11 · PAR-25-158
Closes Nov 17, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
HHS-NIH11 · PAR-25-096
Closes Nov 17, 2026
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-371
Closes Nov 18, 2026
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
HHS-NIH11 · PAR-25-369
Closes Nov 18, 2026
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
HHS-NIH11 · PAR-25-052
Closes Nov 19, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
HHS-NIH11 · PAR-25-226
Closes Nov 19, 2026
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
HHS-NIH11 · PA-23-317
Closes Nov 24, 2026